{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 104,
        "end": 108
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 147,
        "end": 152
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 201,
        "end": 206
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 259,
        "end": 264
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 356,
        "end": 370
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 73,
        "end": 101
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 113,
        "end": 144
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 157,
        "end": 198
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 215,
        "end": 256
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27590272_3",
  "text": "Four important transporter genes are expressed in the kidney , including organic cation transporter 2 ( OCT2 ) , multidrug and toxin extrusion 1 ( MATE1 ) , ATP-binding cassette subfamily B member 1 ( ABCB1 ) , and ATP-binding cassette subfamily C member 2 ( ABCC2 ) , and genetic polymorphisms in these genes may alter the efficacy and adverse effects of platinum drugs ."
}
